StopDown
Analysis · 15 April 2026WholeleafPlant-based chronic pain relief

Wholeleaf founder discusses growth and science

By · Editor ·

  • Wholeleaf makes plant-based products for chronic pain like migraines and joint discomfort
  • Founder Kashish Srivastava gave an interview on April 15, 2026 about the company's progress
  • The startup scaled 16 times in 18 months after appearing on Shark Tank India

What happened

  • Kashish Srivastava is the founder of Wholeleaf.
  • She gave a media interview on April 15, 2026.
  • The article covers her perspective on the company's current status.
  • It highlights the focus on chronic pain management solutions.
  • The discussion includes details about product development and market reach.
  • Growth metrics were shared during the conversation.
  • The company aims to expand its research and development efforts.
  • Accessibility improvements are planned for online and offline channels.

Why it matters

  • Wholeleaf appeared on Shark Tank India previously.
  • This appearance likely boosted brand visibility and customer trust.
  • Chronic pain is a significant global health concern.
  • Plant-based therapeutics offer an alternative to synthetic drugs.

The business

  • Wholeleaf focuses on musculoskeletal and neuropathic pain relief.
  • It uses clinically studied plant actives in its products.
  • Products address joint discomfort, migraines, and menstrual cramps.
  • Slip disc and fibromyalgia relief are also key use cases.
  • Manufacturing follows GMP-certified standards for quality assurance.
  • Third-party testing ensures product safety and efficacy.
  • Ayush Ministry approvals validate the herbal nature of products.
  • Strong repeat usage rates indicate customer satisfaction.
  • The company prioritizes R&D for new pain recovery use cases.

The founders

Kashish Srivastava

Founder
  • She leads Wholeleaf as the primary founder.
  • She appeared on Shark Tank India.
  • She discussed the company's strategic priorities publicly.

In numbers

16XScale growth · past 18 months
4.5XGrowth rate · last year

What happens next

  • Invest in research and development activities.
  • Expand into additional pain and recovery use cases.
  • Strengthen accessibility across online and offline platforms.

Words to know

Neuropathic pain
Pain caused by damage or disease affecting the nervous system.
Musculoskeletal
Relating to the muscles, bones, and joints.
GMP-certified
Good Manufacturing Practice certification ensuring high production standards.
Ayush Ministry
Indian ministry overseeing Ayurveda, Yoga, Unani, Siddha, and Homoeopathy.

The numbers around it

Wholeleaf has 2 funding rounds in StopDown's archive.

#The numbers around it
WhenRoundAmountLed by
8 June 2026seedRs 5 croreIPV
26 February 2026SeedRs 1.5 croreAman Gupta

Healthcare & Life Sciences in April 2026: 6 rounds with a disclosed amount, $15.0 million in all; the biggest was Coral ($12.5M). Every sector this year →

Read it as a card in the app

Terms in this story

  • Startup: A startup is a young company built to find a new way of doing something and to grow fast, usually by serving many customers at little extra cost. India also has a legal definition for scheme benefits: under ten years old, turnover under ₹200 crore, and working on innovation or a scalable model.
  • Shark Tank deal: A Shark Tank India deal is an offer made on camera: money in return for equity, a loan, a royalty or a mix. It is not final when the episode airs. A deal becomes real only after checks and signed papers, and some never close.

Everything on Wholeleaf → · All startup news on 15 April 2026 →

Is this Wholeleaf? Get your “Featured on StopDown” badge →